Clinical Trials Directory

Trials / Completed

CompletedNCT04527770

Midazolam Versus Dexamethasone as an Adjuvant to Local Anesthetics in the Ultrasound Guided Hydrodissection of Median Nerve for Treatment of Carpal Tunnel Syndrome Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
134 (actual)
Sponsor
Minia University · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

midazolam and dexamethasone both can counteract chronic pain. either via GABA mimetic action or via anti prostaglandins

Detailed description

Entrapement syndrome - namely median nerve compression in carpal tunnel syndrome - causes chronic pain that can be refractory to medical treatment . Ultrasound guided hydrodissection is an option for alleviating pain . Recurrence is the main side effect of injection. We try in this research to prevent recurrence rate . Midazolam and dexamethasone both are used in chronic pain . Midazolm act by GABA mimetic action while dexamethasone act by decrease interleukin formation

Conditions

Interventions

TypeNameDescription
DRUGDexamethasoneUltrasound guided median nerve hydrodiseection using dexamethasone or midazolam
DRUGMidazolam injectionintracarpal injection of midazolam and bupivacaine 0.5%

Timeline

Start date
2020-09-01
Primary completion
2021-03-01
Completion
2021-04-30
First posted
2020-08-27
Last updated
2022-02-18

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04527770. Inclusion in this directory is not an endorsement.